Research and development in drug innovation: reflections from the 2013 bioeconomy conference in China, lessons learned and future perspectives
Open Access
- 18 February 2014
- journal article
- review article
- Published by Elsevier BV in Acta Pharmaceutica Sinica. B
- Vol. 4 (2), 112-119
- https://doi.org/10.1016/j.apsb.2014.01.002
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Models for open innovation in the pharmaceutical industryDrug Discovery Today, 2013
- Targeted drug delivery for cancer therapy: the other side of antibodiesJournal of Hematology & Oncology, 2012
- Nanodelivery strategies in cancer chemotherapy: biological rationale and pharmaceutical perspectivesNanomedicine, 2012
- ADME of Antibody–Maytansinoid ConjugatesThe AAPS Journal, 2012
- Therapeutic Antibodies Against CancerHematology/Oncology Clinics of North America, 2012
- Computer-aided antibody design"Protein Engineering, Design and Selection", 2012
- Challenges in Development of Targeted Liposomal TherapeuticsThe AAPS Journal, 2012
- Productivity Shortfalls in Drug Discovery: Contributions from the Preclinical Sciences?: TABLE 1The Journal of pharmacology and experimental therapeutics, 2010
- Lessons from 60 years of pharmaceutical innovationNature Reviews Drug Discovery, 2009
- Can literature analysis identify innovation drivers in drug discovery?Nature Reviews Drug Discovery, 2009